JP2023553697A5 - - Google Patents
Info
- Publication number
- JP2023553697A5 JP2023553697A5 JP2023536866A JP2023536866A JP2023553697A5 JP 2023553697 A5 JP2023553697 A5 JP 2023553697A5 JP 2023536866 A JP2023536866 A JP 2023536866A JP 2023536866 A JP2023536866 A JP 2023536866A JP 2023553697 A5 JP2023553697 A5 JP 2023553697A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- isvd
- specifically binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127224P | 2020-12-18 | 2020-12-18 | |
| US63/127,224 | 2020-12-18 | ||
| EP20306633.7 | 2020-12-21 | ||
| EP20306633 | 2020-12-21 | ||
| PCT/EP2021/086559 WO2022129560A1 (en) | 2020-12-18 | 2021-12-17 | Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553697A JP2023553697A (ja) | 2023-12-25 |
| JP2023553697A5 true JP2023553697A5 (https=) | 2024-10-25 |
| JP7820383B2 JP7820383B2 (ja) | 2026-02-25 |
Family
ID=79283159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536866A Active JP7820383B2 (ja) | 2020-12-18 | 2021-12-17 | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11932702B2 (https=) |
| EP (1) | EP4262985A1 (https=) |
| JP (1) | JP7820383B2 (https=) |
| KR (1) | KR20230123495A (https=) |
| AU (1) | AU2021399955A1 (https=) |
| CA (1) | CA3205422A1 (https=) |
| CO (1) | CO2023009231A2 (https=) |
| IL (1) | IL303783A (https=) |
| MX (1) | MX2023007308A (https=) |
| TW (1) | TW202241947A (https=) |
| WO (1) | WO2022129560A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201805064SA (en) * | 2011-06-23 | 2018-07-30 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| LT3611192T (lt) * | 2015-05-13 | 2025-06-25 | Ablynx N.V. | T ląstelių rekrutingo polipeptidai tcr alfa/beta reaktyvumo pagrindu |
| AU2023290487A1 (en) * | 2022-06-14 | 2025-01-30 | Ablynx Nv | Immunoglobulin single variable domains targeting t cell receptor |
| WO2024118866A1 (en) * | 2022-12-01 | 2024-06-06 | Modernatx, Inc. | Gpc3-specific antibodies, binding domains, and related proteins and uses thereof |
| AR131494A1 (es) | 2022-12-23 | 2025-03-26 | Ablynx Nv | Vehículos de conjugación a base de proteína |
| WO2025051767A1 (en) | 2023-09-04 | 2025-03-13 | Sanofi | Polypeptides for use in the treatment of glypican-3-expressing tumours |
| TW202532432A (zh) * | 2023-09-22 | 2025-08-16 | 比利時商艾伯霖克斯公司 | 二及多價白蛋白結合劑 |
| US20260007757A1 (en) | 2024-06-18 | 2026-01-08 | Ablynx Nv | Antibody-recruiting molecules |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| DK1027439T3 (da) | 1997-10-27 | 2010-05-10 | Bac Ip Bv | Multivalente antigenbindende proteiner |
| WO2004041863A2 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Single domain antibodies directed against interferon- gamma and uses therefor |
| SI1674111T1 (sl) * | 2004-07-09 | 2011-02-28 | Chugai Pharmaceutical Co Ltd | Protitelo proti glipikanu 3 |
| US8188223B2 (en) | 2005-05-18 | 2012-05-29 | Ablynx N.V. | Serum albumin binding proteins |
| AU2007237501A1 (en) | 2006-04-14 | 2007-10-25 | Ablynx N.V. | DP-78-like nanobodies |
| WO2008020079A1 (en) | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| ME02345B (me) * | 2007-07-17 | 2016-08-31 | Squibb & Sons Llc | MONOKLONSKA ANTlTELA PROTIV GLIPIKANA-3 |
| CA2785414C (en) * | 2009-12-25 | 2019-01-22 | Tomoyuki Igawa | Polypeptide modification method for purifying polypeptide multimers |
| EP2723771B1 (en) | 2011-06-23 | 2019-09-11 | Ablynx NV | Serum albumin binding proteins |
| SG10201805064SA (en) | 2011-06-23 | 2018-07-30 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| EP4707303A2 (en) | 2014-05-16 | 2026-03-11 | Ablynx NV | Improved immunoglobulin variable domains |
| MA40764A (fr) * | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
| LT3611192T (lt) | 2015-05-13 | 2025-06-25 | Ablynx N.V. | T ląstelių rekrutingo polipeptidai tcr alfa/beta reaktyvumo pagrindu |
| LT3374392T (lt) | 2015-11-13 | 2022-01-25 | Ablynx Nv | Patobulinti serumo albuminą surišantys imunoglobulino kintami domenai |
| AU2016357460B2 (en) | 2015-11-18 | 2023-07-27 | Ablynx Nv | Improved serum albumin binders |
| US11072666B2 (en) | 2016-03-14 | 2021-07-27 | Chugai Seiyaku Kabushiki Kaisha | Cell injury inducing therapeutic drug for use in cancer therapy |
| BR112019010061A2 (pt) | 2016-11-16 | 2019-08-13 | Ablynx Nv | polipeptídeos de recrutamento de células t capazes de se ligarem ao cd123 e tcr alfa/beta |
| RU2022101604A (ru) | 2016-12-07 | 2022-03-29 | Аблинкс Нв | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином |
| IL267897B2 (en) | 2017-01-17 | 2025-02-01 | Ablynx Nv | Improved serum albumin binders |
| JP7219220B2 (ja) | 2017-01-17 | 2023-02-07 | アブリンクス エン．ヴェー． | 改善された血清アルブミン結合剤 |
-
2021
- 2021-12-17 CA CA3205422A patent/CA3205422A1/en active Pending
- 2021-12-17 MX MX2023007308A patent/MX2023007308A/es unknown
- 2021-12-17 IL IL303783A patent/IL303783A/en unknown
- 2021-12-17 WO PCT/EP2021/086559 patent/WO2022129560A1/en not_active Ceased
- 2021-12-17 AU AU2021399955A patent/AU2021399955A1/en active Pending
- 2021-12-17 US US17/553,908 patent/US11932702B2/en active Active
- 2021-12-17 TW TW110147511A patent/TW202241947A/zh unknown
- 2021-12-17 KR KR1020237024067A patent/KR20230123495A/ko active Pending
- 2021-12-17 EP EP21839545.7A patent/EP4262985A1/en active Pending
- 2021-12-17 JP JP2023536866A patent/JP7820383B2/ja active Active
-
2023
- 2023-07-12 CO CONC2023/0009231A patent/CO2023009231A2/es unknown
-
2024
- 2024-02-05 US US18/432,750 patent/US20240343823A1/en active Pending